首页> 美国卫生研究院文献>World Journal of Surgical Oncology >The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration
【2h】

The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration

机译:穿刺活检作为甲状腺结节诊断的一线药物可减少细针穿刺报告的假阴性和不确定性数据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe reported reliability of core needle biopsy (CNB) is high in assessing thyroid nodules after inconclusive fine-needle aspiration (FNA) attempts. However, first-line use of CNB for nodules considered at risk by ultrasonography (US) has yet to be studied. The aim of this study were: 1) to evaluate the potential merit of using CNB first-line instead of conventional FNA in thyroid nodules with suspicious ultrasonographic features; 2) to compare CNB and FNA as a first-line diagnostic procedure in thyroid lesions at higher risk of cancer.
机译:背景技术在不确定的细针穿刺(FNA)尝试后,已报道的经皮穿刺活检(CNB)评估甲状腺结节的可靠性很高。然而,CNB在超声检查中被认为有危险的结节一线使用尚待研究。这项研究的目的是:1)评估在具有可疑超声特征的甲状腺结节中使用CNB一线替代传统FNA的潜在优点; 2)比较CNB和FNA作为甲状腺癌高危人群的一线诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号